These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 3132928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. General pharmacology of the butanamide derivative S 19812, a new dual inhibitor of cyclooxygenase and lipoxygenase pathways.
    Tordjman C, Andre N, Bresson Y, Bellot I, Deschamps C, Pastoureau P, Wierzbicki M.
    Arzneimittelforschung; 2003; 53(12):844-9. PubMed ID: 14732965
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological profile of SK&F 105809, a dual inhibitor of arachidonic acid metabolism.
    Hanna N, Marshall PJ, Newton J, Schwartz L, Kirsh R, Dimartino MJ, Adams J, Bender P, Griswold DE.
    Drugs Exp Clin Res; 1990; 16(4):137-47. PubMed ID: 2127565
    [Abstract] [Full Text] [Related]

  • 6. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy B, Leblanc Y, Leger S, Mancini J, O'Neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I.
    J Pharmacol Exp Ther; 1999 Aug; 290(2):551-60. PubMed ID: 10411562
    [Abstract] [Full Text] [Related]

  • 7. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H, Yokoyama Y, Motoyoshi S, Ishii K, Imazu C, Seto Y, Kadokawa T, Shimizu M.
    Arzneimittelforschung; 1983 Aug; 33(11):1555-69. PubMed ID: 6607053
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biological evaluation of 2-(4-amino-phenyl)-3-(3,5-dihydroxylphenyl) propenoic acid.
    Xu GL, Liu F, Zhao Y, Ao GZ, Xi L, Ju M, Xue T.
    Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):350-6. PubMed ID: 19744157
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
    Grau M, Guasch J, Montero JL, Felipe A, Carrasco E, Juliá S.
    Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528
    [Abstract] [Full Text] [Related]

  • 13. A sulphonamido-indanone derivative CGP 28237 (ZK 34228), a novel non-steroidal anti-inflammatory agent without gastro-intestinal ulcerogenicity in rats.
    Böttcher I, Schweizer A, Glatt M, Werner H.
    Drugs Exp Clin Res; 1987 Dec; 13(5):237-45. PubMed ID: 3500026
    [Abstract] [Full Text] [Related]

  • 14. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
    Lesch CA, Gilbertsen RB, Song Y, Dyer RD, Schrier D, Kraus ER, Sanchez B, Guglietta A.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH, Rao PN, Knaus EE.
    Bioorg Med Chem; 2006 Dec 01; 14(23):7898-909. PubMed ID: 16904331
    [Abstract] [Full Text] [Related]

  • 16. The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin.
    Barr RM, Black AK, Dowd PM, Koro O, Mistry K, Isaacs JL, Greaves MW.
    Br J Clin Pharmacol; 1988 Jan 01; 25(1):23-6. PubMed ID: 2835975
    [Abstract] [Full Text] [Related]

  • 17. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
    Müller-Peddinghaus R, Kohlsdorfer C, Theisen-Popp P, Fruchtmann R, Perzborn E, Beckermann B, Bühner K, Ahr HJ, Mohrs KH.
    J Pharmacol Exp Ther; 1993 Oct 01; 267(1):51-7. PubMed ID: 8229782
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological studies of a new non-steroidal antiinflammatory drug: 2-(5-ethylpyridin-2-yl)benzimidazole (KB-1043).
    Ito K, Kagaya H, Fukuda T, Yoshino K, Nose T.
    Arzneimittelforschung; 1982 Oct 01; 32(1):49-55. PubMed ID: 6977364
    [Abstract] [Full Text] [Related]

  • 19. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.
    Chan CC, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M.
    J Pharmacol Exp Ther; 1995 Sep 01; 274(3):1531-7. PubMed ID: 7562530
    [Abstract] [Full Text] [Related]

  • 20. 2-[3-(1,1-Dimethylethyl)-5-methoxyphenyloxazolo[4,5-b]pyridine, a new topical antiinflammatory and analgesic compound lacking systemic activity and gastric side effects.
    Bonney RJ, Olson BJ, Bach T, Beveridge G, Goldenberg MM, Gitterman CO, Humes JL, Lu AY, Hucker H, Dougherty H.
    Arzneimittelforschung; 1985 Sep 01; 35(4):715-20. PubMed ID: 3874629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.